Steroid Therapy for Pericardial Effusion

Introduction to Steroid Use

• The European Society of Cardiology recommends administering prednisone 1–1.5 mg/kg daily for at least one month, then taper over a three-month period for a total treatment duration of approximately four months for patients with pericardial effusion 1, 2, 3, 4, 5, 6

When to Use Steroids

• Steroids should not be first-line therapy for pericardial effusion, but are reserved for specific situations such as poor general condition or frequent crises (level of evidence C, indication IIa) 1, 2, 3, 4, 5, 6
• The European Heart Journal suggests that steroids are indicated in cases of contraindication to NSAIDs/colchicine, failure of first-line therapy with NSAIDs and colchicine, or patients on anticoagulants where NSAIDs pose high bleeding risk 1, 2, 3, 4, 5, 6

Specific Steroid Regimen

• The initial dose of prednisone should be 1–1.5 mg/kg daily (or 0.2-0.5 mg/kg/day for lower-dose approach) 1, 2, 3, 4, 5, 6, 9
• The taper should occur over three months, with specific decrements based on current dose 1, 2, 3, 4, 5, 6, 9

Tapering Schedule

• For doses >50 mg/day, decrease by 10 mg every 1-2 weeks 9
• For doses 50-25 mg/day, decrease by 5-10 mg every 1-2 weeks 9
• For doses 25-15 mg/day, decrease by 2.5 mg every 2-4 weeks 9
• For doses <15 mg/day, decrease by 1.25-2.5 mg every 2-6 weeks 9

Critical Management Principles

• If symptoms recur during taper, return to the last dose that suppressed manifestations and maintain that dose for 2-3 weeks before recommencing tapering more gradually 1, 2, 3, 4, 5, 6
• Introduce colchicine or NSAIDs toward the end of the steroid taper and continue anti-inflammatory treatment for at least three months after completing steroid taper 1, 2, 3, 4, 5, 6

Adjunctive Therapy

• Add azathioprine (75-100 mg/day) or cyclophosphamide if inadequate response to steroids alone 1, 2, 3, 4, 5, 6

Bone Protection

• Provide calcium (1,200-1,500 mg/day) and vitamin D (800-1,000 IU/day) supplementation for all patients on glucocorticoids 9
• Consider bisphosphonates for men ≥50 years and postmenopausal women on long-term therapy 9

Monitoring Requirements

• Taper only when asymptomatic and CRP has normalized 7, 8, 9
• Monitor CRP levels to guide treatment duration and assess response 7, 8, 9

Special Context: Histoplasmosis Pericarditis

• For histoplasmosis-related pericardial effusion with severe symptoms, a shorter steroid course is appropriate, with prednisone 0.5-1.0 mg/kg daily (maximum 80 mg daily) and taper over 1-2 weeks 10
• Must add itraconazole (200 mg three times daily for 3 days, then once or twice daily for 6-12 weeks) when using steroids to prevent dissemination 10